In a group of 11 women treated with the GVAX vaccine (autologous tumor cells engineered to secrete GM-CSF) followed by ipilimumab (anti-CTLA-4), one patient had a dramatic fall in her CA-125 levels and 3 other patients achieved stabilization of their disease [11]. This evidence concerns the gene CTLA4 and neoplasm.